Clinical trial
Combined Behavioral/Pharmacological Therapy for Insomnia
NCT00044629 · Duke University, Other · Completed
Key facts
| NCT number | NCT00044629 |
|---|---|
| Title | Combined Behavioral/Pharmacological Therapy for Insomnia |
| Official title | Combined Behavioral/Pharmacological Therapy for Insomnia |
| Lead sponsor | Duke University, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sleep Initiation and Maintenance Disorders |
| Intervention type | Behavioral, Drug |
| Interventions | Cognitive-Behavioral Therapy for Insomnia, zolpidem tartrate (Ambien), Placebo |
| Enrollment | 162 |
| Start date | Sep 1, 2001 |
| Completion | Aug 1, 2006 |
| First posted | Sep 5, 2002 |
| Last update posted | Sep 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: